Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients-Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE)

被引：12

作者：

Pappot, Helle ^{[1
]}

Baeksted, Christina ^{[1
,2
]}

Knoop, Ann ^{[1
]}

Mitchell, Sandra A. ^{[3
]}

Nissen, Aase ^{[2
]}

Johansen, Christoffer ^{[4
]}

机构：

[1] Rigshosp, Finsen Ctr, Dept Oncol, Copenhagen, Denmark

[2] Danish Canc Soc, Documentat & Qual, Copenhagen, Denmark

[3] NCI, Outcomes Res Branch, Div Canc Control & Populat Sci, Rockville, MD USA

[4] Danish Canc Soc Res Ctr, Unit Survivorship, Copenhagen, Denmark

来源：

BREAST JOURNAL | 2019年 / 25卷 / 02期

关键词：

adjuvant chemotherapy; breast cancer; patient reported outcome; PRO-CTCAE; toxicity; FOLLOW-UP;

D O I：

10.1111/tbj.13204

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE) was developed by the National Cancer Institute to capture patient self-reports of symptomatic toxicities during cancer treatment. The aim of this short communication is to describe the design of a national study, which examine the effect of using patients' electronic PRO-CTCAE reporting with real-time feedback to clinicians on treatment events for breast cancer patients receiving adjuvant chemotherapy. The study's end-points are defined as dose reduction, hospitalization, and febrile neutropenia. This is the first report on the impact of PRO-CTCAE in a national breast cancer population during chemotherapy treatment.

引用

页码：269 / 272

页数：4

共 50 条

[31] Incorporating Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) into Dose Review in a Phase I Clinical Trial
Mead-Harvey, Carolyn
Noble, Brie N.
Yee, Claire
Mazza, Gina L.
Langlais, Blake
Patel, Sheetal
Trask, Peter
Rogak, Lauren
Basch, Ethan
Dueck, Amylou C.
Thanarajasingam, Gita
BLOOD, 2024, 144 : 2299 - 2300
[32] Japanese translation and linguistic validation of the us national cancer institute’s patient-reported outcomes version of the common terminology criteria for adverse events (Pro-ctcae)
Miyaji T.
Iioka Y.
Kuroda Y.
Yamamoto D.
Iwase S.
Goto Y.
Tsuboi M.
Odagiri H.
Tsubota Y.
Kawaguchi T.
Sakata N.
Basch E.
Yamaguchi T.
Journal of Patient-Reported Outcomes, 1 (1)
[33] Dutch translation and linguistic validation of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™)
Veldhuijzen, Evalien
Walraven, Iris
Mitchell, Sandra A.
Moore, Elizabeth Yohe
McKown, Shawn M.
Lauritzen, Matthew
Kim, Katherine J.
Belderbos, Jose S. A.
Aaronson, Neil K.
JOURNAL OF PATIENT-REPORTED OUTCOMES, 2020, 4 (01)
[34] Dutch translation and linguistic validation of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Veldhuijzen, Aaltje E.
Belderbos, Jose S. A.
Mitchell, Sandra A.
McKown, Shawn M.
Lauritzen, Matthew
Moore, Elizabeth Yohe
Kim, Katherine J.
Walraven, His
Aaronson, Neil K.
QUALITY OF LIFE RESEARCH, 2018, 27 : S67 - S68
[35] Translation and linguistic validation of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™) in 10 languages
Mitchell, Sandra
Moore, Elizabeth Yohe
McKown, Shawn
Poepsel, Timothy
Lauritzen, Matthew
Campbell, Alicyn
Piault, Elisabeth
Zarzar, Katherine
Kim, Katherine
QUALITY OF LIFE RESEARCH, 2018, 27 : S25 - S25
[36] Psychometric properties of patient-reported outcomes Common Terminology Criteria for adverse events (PRO-CTCAE®) in breast cancer patients: The prospective observational multicenter VIP study
Caminiti, Caterina
Maglietta, Giuseppe
Arenare, Laura
Di Liello, Raimondo
Migliaccio, Gessica
Barberio, Daniela
De Laurentiis, Michelino
Di Rella, Francesca
Nuzzo, Francesco
Pacilio, Carmen
Iodice, Giovanni
Orditura, Michele
Ciardiello, Fortunato
Di Bella, Sara
Cavanna, Luigi
Porta, Camillo
Giovanardi, Filippo
Ripamonti, Carla Ida
Bilancia, Domenico
Aprile, Giuseppe
Ruelle, Tommaso
Diodati, Francesca
Piccirillo, Maria Carmela
Iannelli, Elisabetta
Pinto, Carmine
Perrone, Francesco
BREAST, 2024, 77
[37] Dutch translation and linguistic validation of the U.S. National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™)
Evalien Veldhuijzen
Iris Walraven
Sandra A. Mitchell
Elizabeth Yohe Moore
Shawn M. McKown
Matthew Lauritzen
Katherine J. Kim
José S. A. Belderbos
Neil K. Aaronson
Journal of Patient-Reported Outcomes, 4
[38] Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
Minji K. Lee
Benjamin D. Schalet
David Cella
Kathleen J. Yost
Amylou C. Dueck
Paul J. Novotny
Jeff A. Sloan
Journal of Patient-Reported Outcomes, 4
[39] Statistical properties of items and summary scores from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE®) in a diverse cancer sample
Mead-Harvey, Carolyn
Basch, Ethan
Rogak, Lauren J.
Langlais, Blake T.
Thanarajasingam, Gita
Ginos, Brenda F.
Lee, Minji K.
Yee, Claire
Mitchell, Sandra A.
Minasian, Lori M.
Mendoza, Tito R.
Bennett, Antonia, V
Schrag, Deborah
Dueck, Amylou C.
Mazza, Gina L.
CLINICAL TRIALS, 2024,
[40] Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
Lee, Minji K.
Schalet, Benjamin D.
Cella, David
Yost, Kathleen J.
Dueck, Amylou C.
Novotny, Paul J.
Sloan, Jeff A.
JOURNAL OF PATIENT-REPORTED OUTCOMES, 2020, 4 (01)

← 1 2 3 4 5 →